Core Laboratories Inc. Common Stock (NY:CLB)

9.750 -0.410 (-4.04%)

Delayed Quote Updated: 3:58 PM EDT, Oct 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Core Laboratories Inc. Common Stock

< Previous 1 2 3 4 5 Next >

Earnings Scheduled For January 29, 2025 ↗

January 29, 2025

Via Benzinga

A Preview Of Core Laboratories's Earnings ↗

January 30, 2024

Via Benzinga

Core Laboratories (CLB) Q2 2023 Earnings Call Transcript ↗

July 27, 2023

CLB earnings call for the period ending June 30, 2023.

Via The Motley Fool

Arm Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

December 23, 2024

Via Benzinga

Why Rumble Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket ↗

December 23, 2024

Shares of Rumble Inc.

Via Benzinga

Core Laboratories (CLB) Q3 2024 Earnings Call Transcript ↗

October 24, 2024

CLB earnings call for the period ending September 30, 2024.

Via The Motley Fool

Topics Earnings

Core Laboratories (CLB) Q2 2024 Earnings Call Transcript ↗

July 25, 2024

CLB earnings call for the period ending June 30, 2024.

Via The Motley Fool

Topics Earnings

Earnings Preview: Core Laboratories ↗

July 25, 2023

Via Benzinga

4 Analysts Have This to Say About Core Laboratories ↗

June 30, 2023

Via Benzinga

The Latest Analyst Ratings for Core Laboratories ↗

May 01, 2023

Via Benzinga

Core Laboratories (CLB) Q1 2023 Earnings Call Transcript ↗

April 28, 2023

CLB earnings call for the period ending March 31, 2023.

Via The Motley Fool

CLB Stock Earnings: Core Laboratories Beats EPS, Misses Revenue for Q2 2024 ↗

July 24, 2024

CLB stock results show that Core Laboratories beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

Via InvestorPlace

Gateway Group Announces Preliminary Sponsors and Additional Presenting Companies for September Gateway Conference

July 16, 2024

Executives from a Range of Industries to Present to 300+ Institutional Investors and Analysts in San Francisco on September 4-5, 2024

From Gateway Group

Via GlobeNewswire

Sanofi Reports Strong Earnings, Joins Kirby, Sonic Automotive, Union Pacific And Other Big Stocks Moving Higher On Thursday ↗

April 25, 2024

Via Benzinga

CLB Stock Earnings: Core Laboratories Beats EPS, Beats Revenue for Q1 2024 ↗

April 24, 2024

CLB stock results show that Core Laboratories beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Top Cannabis Appointments You Should Know About: Aurora's New CFO And Other Changes ↗

February 20, 2024

Cannabis multi-state operator Cresco Labs kicked off February by announcing the promotion of Greg Butler to the position of president. Tom Shuman, a CPG sales and marketing veteran, agreed to serve as...

Via Benzinga

Topics Cannabis

Core Laboratories (CLB) Q4 2023 Earnings Call Transcript ↗

February 01, 2024

CLB earnings call for the period ending December 31, 2023.

Via The Motley Fool

Topics Earnings

February Risk Alert: 3 Stocks to Unload Now to Protect Your Portfolio ↗

January 09, 2024

Discover the hidden pitfalls in the investment world with a deep dive into these three stocks to sell now to protect your portfolio.

Via InvestorPlace

Earnings Scheduled For January 31, 2024 ↗

January 31, 2024

Companies Reporting Before The Bell • Novartis (NYSE:NVS) is likely to report quarterly earnings at $1.68 per share on revenue of $11.56 billion.

Via Benzinga

3 Oil Stocks to Sell in January Before They Crash and Burn ↗

January 02, 2024

You have until the end of the month to dump these oil stocks before they crash. Do you have these three in your portfolio?

Via InvestorPlace

Core Laboratories (CLB) Q3 2023 Earnings Call Transcript ↗

November 02, 2023

CLB earnings call for the period ending September 30, 2023.

Via The Motley Fool

Topics Earnings

MarketBeat ‘Stock of the Week’: Halliburton Is One Slick Oil Play

October 16, 2023

Halliburton’s commitment to technological innovation is a differentiator — and its undervalued stock a potential opportunity for long-term investors.

Via MarketBeat

Northrop Grumman, General Dynamics, Lockheed Martin And Other Big Stocks Moving Higher On Monday ↗

October 09, 2023

U.S. stocks traded lower, with the Dow Jones falling around 50 points on Monday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Halliburton And Core Laboratories Collaborate To Accelerate Digital Rock Data Solutions ↗

October 09, 2023

Halliburton Company (NYSE: HAL) and Core Laboratories Inc. (NYSE: CLB) announced a strategic alliance aimed at expediting the delivery of

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2023 ↗

June 30, 2023

Via Benzinga

Crude Oil Rises 2%; LumiraDx Shares Spike Higher ↗

June 21, 2023

U.S. stocks traded lower toward the end of trading, with Nasdaq Composite dropping over 100 points on Wednesday. The Dow traded down 0.04% to 34,040.13 while the NASDAQ fell 0.77% to 13,562.00. The S&P...

Via Benzinga

Russia-Saudi Output Clashes, Goldman Forecast Cuts Shake The Market: 5 Oil Services Stocks That Are Weathering the Storm ↗

June 12, 2023

Via Benzinga

Nasdaq, Methanex And Other Big Stocks Moving Lower On Monday ↗

June 12, 2023

U.S. stocks traded higher, with the Nasdaq Composite rising around 70 points on Monday. Here are some big stocks recording losses in today’s session. Beneficient (NASDAQ: BENF) shares fell 17% to...

Via Benzinga

Why Core Laboratories, Gran Tierra Energy, and NexTier Oilfield Solutions Rallied Today ↗

April 03, 2023

OPEC members surprised the market with another oil production cut, which lifted these small-cap oil-related stocks.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2023 ↗

April 18, 2023

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.